MedTrace Logo

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction

NCT05870488 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-02-10

No results posted yet for this study

Summary

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.

Conditions

  • Sacroiliac Joint Dysfunction
  • Sacroiliac; Fusion
  • Sacroiliac Disorder
  • Sacroiliac Joint Pain

Interventions

DEVICE

Use of iFuse TORQ

Use of iFuse TORQ for the treatment of SI Joint dysfunction

Sponsors & Collaborators

  • SI-BONE, Inc.

    lead INDUSTRY

Principal Investigators

  • Stacie Tran, MPH · SI-BONE

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-23
Primary Completion
2025-04-23
Completion
2027-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870488 on ClinicalTrials.gov